Advance novel TB drug regimens

IATI Identifier: US-EIN-13-4128413-Gpaf-2016
Published in IATI IATI
  • date_range Apr 01, 2013
  • autorenew Implementation (Status)

TB Alliance is focused on: 1. Improved TB therapeutic regimens that are developed, registered, and available to those who need them -- making a major impact on the global TB pandemic 2. Progress is made on the development of new compounds that offer promise to hit novel targets and achieve in vivo cure of TB in optimized combinations in 8-12 weeks and the best potential combinations are assessed for clinical regimen development.

more_horiz
Sectors:
  • error
    Sector code:
    43082 -
    Sector vocabulary:
    7 -

Participating Organisations

Organisation Name Organisation Type Organisation Role
Department of International Development, United Kingdom (UKAID) Government Funding

Transaction

Transaction Value Provider Receiver Type Date
54,033,661 USD (Valued at Dec 31, 2016) circle Provider N/A circle Receiver N/A Expenditure date_rangeDec 31, 2016

Budget

114,799,834 USD
50,116,067 USD (Valued at Aug 21, 2017) date_range Jan 01, 2017 - Dec 31, 2017
10,880,010 USD (Valued at Aug 21, 2017) date_range Jan 01, 2018 - Dec 31, 2018
53,803,757 USD (Valued at Aug 22, 2017) date_range Jan 01, 2016 - Dec 31, 2016
access_timeUpdated on Aug 23, 2017 16:38:10
View XML file here